@misc{indiciae8aed0bcf77f9,
  title = {Dyrk1a inhibition with the Novel Compound DYR533: A Cross-Disease Therapeutic Strategy Targeting Amyloidosis, Tau Pathogenesis, and Neuroinflammation},
  author = {Bartholomew, S. K. and Turk, J. and Winslow, W. and Foley, C. and Shaw, A. and Rokey, S. and Tallino, S. and Judd, J. M. and Beach, T. G. and Serrano, G. E. and Wilms, G. and Kushwaha, R. and McMahon, A. and Ginn, S. and Becker, W. and Hulme, C. and Dunckley, T. and Velazquez, R.},
  year = {2026},
  doi = {10.64898/2026.01.20.700091},
  url = {https://www.biorxiv.org/content/10.64898/2026.01.20.700091v1},
  note = {Source identifier: 10.64898/2026.01.20.700091}
}